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The cellular transcription factors Sp1 and NF-kB were upregulated shortly after the binding of purified live
or UV-inactivated human cytomegalovirus (HCMV) to the cell surface. The rapid time frame of transcription
factor induction is similar to that seen in other systems in which cellular factors are induced following
receptor-ligand engagement. This similarity suggested that a cellular receptor-viral ligand interaction might be
involved in Sp1 and NF-kB activation during the earliest stages of HCMV infection. To focus on the possible
role viral ligands play in initiating cellular events following infection, we first used purified viral membrane
extracts to demonstrate that constituents on the membrane are responsible for cellular activation. Addition-
ally, these studies showed, through the use of neutralizing antibodies, that the viral membrane mediators of
this activation are the major envelope glycoproteins gB (UL55) and gH (UL75). To confirm these results,
neutralizing anti-gB and -gH antibodies were used to block the interactions of these glycoproteins on whole
purified virus with their cell surface receptors. In so doing, we found that Sp1 and NF-kB induction was
inhibited. Lastly, through the use of purified viral gB protein and an anti-idiotypic antibody that mimics the
image of the viral gH protein, it was found that the engagement of individual viral ligands with their
appropriate cell surface receptors was sufficient to activate cellular Sp1 and NF-kB. These results support our
hypothesis that HCMV glycoproteins mediate an initial signal transduction pathway which leads to the
upregulation of host cell transcription factors and suggests a model wherein the orderly sequence of virus-
mediated changes in cellular activation initiates with viral binding via envelope glycoproteins to the cognate
cellular receptor(s).
One of the hallmarks of human cytomegalovirus (HCMV)
infection is the massive induction and dysregulation of nor-
mally tightly regulated cellular transcription factors, including
NF-kB, Sp1, and others (1, 8, 9, 28, 33, 62, 78, 79), and because
HCMV is associated with a wide range of clinical symptoms in
which cellular activation occurs (33), it is possible that this
virus-mediated cellular event is linked to viral pathogenicity.
Previously, it was demonstrated that infection resulted in a
rapid induction of nuclear NF-kB and increased steady-state
message levels for the two classical NF-kB subunits, p50 and
p65 (9, 49, 78). In addition, it was shown that the promoters for
these two subunits are transactivated during infection and that
the major viral immediate-early (IE) gene products play a role
in this transactivation (78). There was also an upregulation of
the usually constitutively expressed Sp1 during HCMV infec-
tion (79). The observed HCMV-induced increase in Sp1 levels
may be the cause of the upregulation of p65 expression be-
cause the Sp1 sites present in the p65 promoter were shown to
be critical for transactivation of the p65 promoter during in-
fection (79). The importance of the induction of these host cell
factors stems from their critical role during infection in the
regulation of the major IE promoter (MIEP) and the regula-
tion of the IE genes and, consequently, the entire gene cascade
(13, 28, 62, 66). Specifically, NF-kB binds to and is essential for
transactivation of the MIEP (13, 62), while Sp1, although stud-
ied in less detail, can also significantly transactivate the MIEP
(77). The essential role for NF-kB in the viral life cycle is
further underscored by the fact that no other stimulus has been
found to induce the normally constitutively expressed p65 gene
product (49, 78). In addition, it is intriguing to consider that
the proto-oncogenes (c-fos, c-jun, and c-myc) which are rapidly
induced following HCMV infection and are suggested to be
one of the driving forces behind the stimulation of cellular
DNA synthesis and proliferation during infection (8) have
functional or potentially functional kB (26, 27, 45) and/or Sp1
(12, 46, 52, 70) binding sites in their promoters. Therefore,
because of the coupling of virus-induced transcription factors
to the regulation of the viral life cycle, we have focused on the
mechanisms involved in the regulation of two critical players,
NF-kB and Sp1, during HCMV infection.
NF-kB or classical NF-kB is a heterodimer composed of two
members of the rel family of transcription factors: a 50-kDa
subunit (p50 or NF-kB1) and a 65-kDa subunit (p65 or RelA)
(reviewed in references 5, 64, and 69). In addition to classical
NF-kB, other rel family transcriptional regulators exist (5, 64,
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69). Under nonstimulatory conditions, NF-kB is stored in the
cytosol primarily complexed to an inhibitor termed IkBa (3–5,
30, 64, 69). During stimulation, NF-kB is rapidly released from
its inhibitor, allowing its mobilization to the nucleus (5, 25, 64,
69). Sp1 is a member of a family of transcription factors known
to bind to specific GC-rich elements (23, 24, 36, 47). The
mechanisms involved in the control of Sp1 activity remains
unknown but may involve an elusive inhibitory molecule (12,
70) which possibly binds free Sp1, blocking its transcriptional
abilities. pRb and other Sp family members can also play a role
in the regulation of Sp1 function (12, 46, 51, 52, 70, 71).
Previous investigations of the viral regulation of cellular
transcription factors in HCMV infection have demonstrated
that at least two steps or tiers are involved. First, through an
unknown mechanism, there is an initial upregulation or mobi-
lization of factors which occurs within minutes after virus-cell
interaction, is protein synthesis independent (9, 78), and prob-
ably results from the release of cytosolic stores through the
disruption of inhibitory complexes (for NF-kB, this would in-
volve the NF-kB/IkB complex [49, 73, 78], and for Sp1, this
might involve the several described inhibitors [12, 70]). Second,
there is a synthesis of new molecules in a protein synthesis-
dependent step via transactivation of the p105/p50 and p65
promoters (new NF-kB molecules) and also, possibly, the Sp1
promoter (new Sp1 molecules) beginning at early times after
infection and continuing through the course of infection (78,
79). This second tier of transcription factor induction has been
documented to be mediated by a combination of cellular fac-
tors and viral IE products (78, 79).
The steps involved in the initial tier of regulation are un-
known. However, because the rapid kinetics of NF-kB activa-
tion by HCMV infection (9, 78) is reminiscent of the NF-kB
induction following cytokine and/or mitogen treatment, a
known receptor-ligand-mediated interaction (5, 64, 69), we
hypothesized that a similar event, a virus-regulated receptor-
ligand interaction, might exist following HCMV infection. This
hypothesis is supported by evidence that upon HCMV infec-
tion, many of the IE events that take place, including Ca21
flux, phospholipid turnover, induction of second messengers,
and induction of the proto-oncogenes, are similar to events
that occur following known receptor-ligand interactions in
other systems (for reviews, see references 1, 2, 7, and 76). The
possibility of a viral ligand-mediated IE signaling event occur-
ring during HCMV infection is also supported by studies doc-
umenting that many viruses initiate infection by binding to
what have been called cellular “adhesion” receptors (6, 20, 21,
48, 53, 56, 65, 68, 72), many of which are considered “activa-
tional” receptors (76).
If a receptor-ligand interaction were involved in this early
viral step of cellular activation, the most likely ligand candi-
dates would be the viral envelope glycoproteins (35, 58). Based
on homology to herpes simplex virus, HCMV encodes two
major glycoproteins, gB (UL55, gcI [18, 58]) and gH (UL75,
gcIII [19, 57]). The believed role for these viral glycoproteins is
in virus attachment to the cell surface and in the ensuing virus
fusion and entry (15, 16, 29, 38, 54, 55, 65). gB is a posttrans-
lationally processed, disulfide-linked heterodimer found on the
viral envelope (10, 18, 29, 58) that is important in virion pen-
etration and fusion (54). In addition, gB has been shown to
bind to heparan sulfate proteoglycans and annexin II on the
cell surface (15, 17, 75). The second major envelope glycopro-
tein, gH (19, 35, 57), is complexed to gL (UL115 [37], of which
little is known), has been shown to bind to a ubiquitously
expressed 92.5-kDa cellular phosphoprotein found on most
cell types (39, 42), and is also important in virus fusion (38).
Our hypothesis for a potential role of HCMV glycoproteins
in mediating a signal transduction pathway is further supported
by evidence that the engagement of the 92.5-kDa cellular gH
receptor by an anti-idiotypic antibody, which mimics HCMV
gH, results in a rapid increase in cytoplasmic and nuclear
[Ca21] (40), as well as an increase in phosphorylation of the
92.5-kDa receptor (41). To address the nature of the first tier
of regulation, we focused on the initial cellular events that
occur following virus binding. We showed that present on the
viral envelope are the factors necessary for transcription factor
induction and that viral glycoproteins gB and gH can upregu-
late Sp1 and NF-kB levels. These results provide evidence that
the receptor-ligand engagement that occurs during viral bind-
ing generates a sufficient signal to initiate the cellular signal
transduction pathway and suggests that upon binding to the
cell, HCMV attempts to mimic a cellular activation process to
possibly set the stage for viral gene expression.
MATERIALS AND METHODS
Cell culture and virus. Methods for HCMV Towne strain (passages 42 to 43)
culture in human embryonic lung (HEL) fibroblasts have been described previ-
ously (31, 78). Prior to infection, HEL fibroblasts were subcultured in Eagle’s
minimum essential medium (MEM) supplemented with 10% fetal bovine serum
(Hyclone, Logan, Utah) at 37°C in a 5% CO2 incubator. Cells were infected with
only gradient-purified virus at a multiplicity of infection of 2 to 3 and incubated
at 37°C in Eagle’s MEM supplemented with 4% heat-inactivated fetal bovine
serum (Hyclone) in a 5% CO2 incubator for the various times stated in Result
(from mock infection [uninfected or untreated] through 4 h postinfection).
HCMV was gradient purified and used to infect cells as previously described
(32). UV-inactivated virus was prepared as previously described (8) and was used
in the same manner as live virus. The UV-inactivated virus did not replicate or
produce any detectable levels of IE gene products.
Purification of viral membrane extracts. Gradient-purified virus was incu-
bated in a lysis buffer (0.5% Nonidet P-40 [NP-40], 0.01 M Tris-HCl [pH 8.0],
0.15 M NaCl, 0.025% NaN3) for 15 min at 4°C and then carefully layered onto
a 30% sucrose cushion. The samples were then spun at 200,000 3 g for 90 min
at 25°C. The membrane fraction sitting above the sucrose cushion was collected
and extensively dialyzed to phosphate-buffered saline (PBS) and then to Eagle’s
MEM and finally stored at 270°C until use. Contamination of the membrane
with capsid components was checked by Western blot analysis. Equal-protein
amounts of the purified membrane fraction and gradient-purified virus were used
in the selected experiments.
gB plasmids, expression, and purification. The HCMV gB gene was amplified
by using Taq polymerase from the genomic DNA of HCMV (Towne strain) by
PCR with primers 59-TGGATTTGGCAAGCTTCGAACATGGA-39 and 59-G
ACACGGCCAAAGCTTGTCATGACTC-39. The gB sequence was confirmed
by DNA sequencing analysis. Plasmid pcGB3 was constructed by digestion of the
amplified gene with HindIII (Promega, Madison, Wis.) and inserted into plasmid
pcDNA3 (Invitrogen, Portland, Oreg.). 293T cells were then transfected with the
pcGB3 vector by the calcium phosphate method. Cells were then cloned and
isolated by limiting dilution and examined by immunofluorescent staining with
anti-HCMV gB-specific monoclonal antibodies (MCMVA98 [34] and 13-127-100
[Advanced Biotechnologies Inc., Columbia, Md.]). gB1 cells were grown in
Eagle’s MEM supplemented with 10% fetal bovine serum (Hyclone) at 37°C in
a 5% CO2 incubator, collected, and lysed in a lysis buffer (10 mM Tris-HCl (pH
7.5) 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride [PMSF; Sigma, St. Louis,
Mo.], 1% NP-40) for 1 h at 4°C. After clarification by centrifugation, the lysate
was reacted with lentil (Lens culinaris) lectin-Sepharose 4B beads (Sigma) at
25°C for 1 h. The incubated product was then washed five times in a washing
buffer (10 mM Tris-HCl [pH 7.5], 1 mM EDTA, 1 mM PMSF, 0.5% NP-40), and
the attached protein was eluted with 0.5 M a-methyl-D-mannopyranoside (Al-
drich Scientific, Milwaukee, Wis.). The eluted protein was next electrophoresed
on a 5% nondenaturing polyacrylamide gel, and the gB fragment was cut out (the
fragment position was identified by Western blot analysis with specific anti-gB
monoclonal antibodies (MCMVA98 and 13-127-100) and by Coomassie blue
(Sigma) staining or silver staining (BioRad Kit; BioRad, Richmond, Calif.). The
gB protein was then electroeluted and stored at 4°C until use. Simultaneous with
harvesting of the purified gB product, a control protein lysate was harvested from
parental 293T cells by the protocol described above.
Antibodies and cellular activation. For experiments involving cellular activa-
tion with purified membrane fractions, cells were incubated with a protein
amount of purified viral membrane fractions equal to that found in the purified
virus used to infect cells in those experiments or the same amount of purified
membrane fractions preincubated with 20 mg of protein G affinity-purified mu-
rine monoclonal anti-gB (15D8 [60]) and anti-gH (1G6 [61]) antibodies of the
immunoglobulin G2A [IgG2A] isotype for 1 h at 4°C prior to use. Different
concentrations of antibody and membrane fractions were also used (data not
shown). For various experiments involving antibody blocking of the gradient-
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purified virus, virus was preincubated with monoclonal anti-gB antibodies (4 and
20 mg of 15D8 or a 1:100 dilution of an ascites fluid preparation of CH177-3,
CH432-1, and CH436-1 [54, 59], depending on the experiment), anti-gH antibody
(4 and 20 mg of 1G6), both anti-gB (15D8) and -gH (1G6) antibodies, or a
protein G affinity-purified murine monoclonal control antibody (4 and 20 mg of
an anti-human prostate-specific antigen (PSA) antibody [control antibody] of the
IgG2A isotype) for 1 h at 4°C. For neutralization with the 15D8 monoclonal
antibody, 2% guinea pig complement (Accurate Scientific, Westbury, N.Y.) was
added. Where appropriate, complement alone or complement plus the control
antibody was used (data not shown). The neutralizing antibodies used in the
experiments prevented virus-mediated cytopathic effects and viral gene expres-
sion in fibroblasts as confirmed by side-by-side experiments in which these vari-
ables were assessed (data not shown). In addition, 15 and 60 ng of purified viral
gB or purified viral gB blocked with antibodies (5 mg of 15D8 and 1G6 or the
control antibody) were used in some studies to stimulate cells. In other studies,
50 mg of the 4-3-5 affinity-purified murine anti-idiotypic IgM antibody (38, 43),
which mimics the HCMV viral gH product and is thus specific for the 92.5-kDa
cellular gH receptor (42), or an IgM control antibody (affinity-purified mouse
IgM [Southern Biotechnology Associates, Birmingham, Ala.]) plus 10 mg of the
appropriate cross-linking antibody (goat anti-mouse IgM antibody [Southern
Biotechnology Associates]) was used to stimulate cells as previously described
(40, 41). In all cases of cellular stimulation (purified virus, purified viral mem-
brane extracts, purified gB, anti-idiotypic antibody, or the various control prod-
ucts), the cells were treated the same (washed identically, incubated in an equal
volume of product and medium, incubated for the same length of time, and
harvested in the same manner) to allow comparisons between groups. In all
cases, mock samples were treated in a manner similar to that of the test samples
(except that no virus, membrane extracts, etc. were added) and incubated for the
maximal length of test sample stimulation. All experiments were repeated two to
four times.
Nuclear extract isolation. Isolation of nuclear extracts has been described
elsewhere (49, 78). Briefly, collected cell pellets were incubated for 4 min on ice
with a cytoplasmic isolation buffer (10 mM N-2-hydroxyethylpiperazine-N9-2-
ethanesulfonic acid [HEPES, pH 7.6], 60 mM KCl, 1 mM EDTA, 0.1% NP-40,
1 mM dithiothreitol, 1 mM PMSF [Sigma], 2 mM phenanthroline [Sigma], 250
mM dichloroisocoumarin [Sigma], 100 mM E-64 [Sigma], 10 mM pepstatin A
[Sigma]). After collection by centrifugation, the nuclear pellets (the cytoplasmic
extracts were not used in these experiments) were washed in a cytoplasmic
isolation buffer without NP-40, spun, and then incubated for 10 min on ice with
a nuclear isolation buffer (20 mM Tris-HCl [pH 8.0], 420 mM NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, 0.5 mM PMSF [Sigma], 25% glycerol, 2 mM phenanth-
roline [Sigma], 250 mM dichloroisocoumarin [Sigma], 100 mM E-64 [Sigma], 10
mM pepstatin A [Sigma]). Supernatants containing the nuclear extracts were
collected and stored at 270°C.
Electrophoretic mobility shift assays (EMSAs). Collected nuclear extracts
were incubated for 15 min in a binding buffer (10 mM Tris-HCl [pH 7.9], 50 mM
NaCl, 0.5 mM EDTA, 10% glycerol, 1 mM dithiothreitol)–7.5 mM MgCl2–0.1 mg
of poly(dI-dC) with a 32P-labeled wild-type (WT) GC box (59-CCTTTTTAAG
GGGCGGGGCTT-39) or a mutant (MUT) GC box 59-CCTTTTTAAGGTTC
GGGGCTT-39) double-stranded oligonucleotide probe for the experiments ex-
amining Sp1 activity and a major histocompatibility complex (MHC) WT kB
binding site (59-CCTTTTTTTTTGGGGATTCCCCA-39) or a MUT kB binding
site (59-CCTTTTTTTTTGCGGCTTCCCGA-39) double-stranded oligonucleo-
tide probe for experiments examining NF-kB activity. The annealed double-
stranded oligonucleotide probes with T overhangs and C ends were labeled by
filling in the recessed 39 ends of the oligonucleotide with [a-32P]dATP (ICN,
Irvine, Calif.) by using Klenow (Boehringer Mannheim, Indianapolis, Ind.),
followed by a chase with cold dATP and dGTP, and then finally column purified
with G-25 Sephadex (Boehringer Mannheim). The samples were electropho-
resed on a 5% polyacrylamide gel, dried, and developed with intensifier screens
at 270°C. Antibodies were used to supershift the specific complexes of interest
by pretreating the extracts for 15 min to 1 h at 4°C with 1 mg of antibody prior
to their addition to the binding buffer, MgCl2, poly (dI-dC), and labeled probes.
Commercial anti-Sp1 antibody and its appropriate blocking peptide (Santa Cruz
Biotechnology, Inc., Santa Cruz, Calif.) and specific antibodies to p50 and p65
and their appropriate blocking peptides (a generous gift from Albert S. Baldwin,
Jr. [14, 63]) were used in the supershift experiments. Blocking peptides were
preincubated with the supershifting antibodies for 1 h at 4°C prior to their
incubation with the various nuclear extracts.
Western blot analysis. Samples for Western blot analysis were prepared by
boiling the samples in a sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis sample buffer prior to use. The same amount of protein was added to each
lane. Samples were subjected to sodium dodecyl sulfate–10% polyacrylamide gel
electrophoresis, and the proteins were transferred overnight to a nitrocellulose
membrane (Immobilon-P; Millipore Corporation, Bedford, Mass.). The blots
were then blocked in a 5% skim milk–0.1% Tween 20–PBS solution for 1 h,
followed by incubation in a 2% skim milk–0.1% Tween 20–PBS solution for 1 h
with the primary antibody, 1:400 aUL94 (74), 1:2,500 agB (Advanced Biotech-
nologies Inc.), 1:1,000 aIE1-72 (6E1 [78]), or 1:500 app65/UL83. Next, the blots
were washed, incubated with a 1:2,500 dilution of the appropriate horseradish
peroxidase-conjugated secondary antibody in a 2% skim milk–0.1% Tween 20–
PBS solution for 1 h (Sigma), washed again, and finally incubated with the
developing agents and developed in accordance with the ECL protocol (Amer-
sham Life Sciences, Arlington Heights, Ill.). For gB isolation, a PBS-skim milk-
Tween 20 solution containing either a 1:1,000 anti-gB antibody (Advanced Bio-
technologies Inc.) or a 1:100 dilution of serum from an HCMV-seropositive
individual was used. The blots were washed and reacted for 1 h with a 1:10,000
dilution of the appropriate alkaline phosphatase-conjugated secondary antibody
(Promega). The blots were developed by colorimetric assay using 3.3 mg of
nitroblue tetrazolium (Promega) per ml and 1.6 mg of 5-bromo-4-chloro-3-
indolylphosphate (Promega) per ml for 30 min at 25°C.
RESULTS
Viral infection upregulated cellular transcription factors
Sp1 and NF-kB in a rapid manner. To better detail the IE
changes in cellular transcription factors following HCMV
binding to the cell surface, we examined by EMSA the rapid
induction of nuclear Sp1 and NF-kB activity following the
incubation of HEL fibroblasts with gradient-purified virus. The
data shown in Fig. 1 demonstrated that both of these important
cellular factors were rapidly upregulated after viral incubation
(approximately fivefold induction of both transcription factors
was seen by 60 min). An increase in Sp1 activity was seen by as
early as 30 min following viral incubation (Fig. 1A), and an
increase in NF-kB activity was seen by as early as 15 min
following virus addition (Fig. 1B). In addition, to demonstrate
the specificity of transcription factor induction, we also exam-
ined in the same nuclear extracts the induction of activated
transcription factor–cyclic AMP response element-binding
protein (ATF/CREB) DNA binding activity, which was re-
ported to be induced only at late times of infection (44). The
results of this experiment showed that ATF/CREB binding
activity (data not shown) was not induced during IE times of
infection like NF-kB and Sp1. Supershifting antibodies showed
that the shifted bands were bona fide Sp1 (Fig. 1C, super-
shifted band marked with an asterisk) and NF-kB (p50/p65)
and p50/p50 homodimers (Fig. 1D, supershifted bands marked
with asterisks). The appropriate blocking peptides showed the
specificity of the supershifting antibodies. Although Sp1 was
the major component of the shifted complex (Fig. 1C), induc-
tion of a lesser concentration of other GC box-binding proteins
was also detected during infection (the nature of these other
GC box-binding proteins is unknown). Binding of the nuclear
extracts to mutated GC box or MHC probes was also assayed
(compare the binding of extracts to the WT GC BOX or WT
MHC oligonucleotides to the binding to the MUT GC BOX
and MUT MHC oligonucleotides), and the lack of specific
bands confirmed the specificity of the identified bands. In ad-
dition, in competition experiments, the Sp1 bands were specif-
ically competed with an excess of the unlabeled WT GC BOX
oligonucleotide but not by an excess of the unlabeled MUT GC
BOX oligonucleotide, and the p50/p65 and p50/p50 bands
were specifically competed with an excess of unlabeled WT
MHC oligonucleotides but not unlabeled MUT oligonucleo-
tides (data not shown). UV-inactivated virus also rapidly in-
duced both Sp1 and NF-kB (Fig. 1A and B, respectively),
supporting the work of Boldogh et al., who demonstrated that
gradient-purified and UV-inactivated viruses had identical ef-
fects on the cellular changes they examined (8, 9). This rapid
induction of cellular factors following HCMV incubation is
consistent with our hypothesis that a viral ligand-cellular re-
ceptor interaction is responsible for an early step of cellular
activation.
Purified HCMV membrane extracts induced Sp1 and NF-kB
DNA binding activity, and gB and gH antibodies blocked this
induction. The rapid upregulation of transcription factors fol-
lowing HCMV infection suggests that viral membrane glyco-
proteins might play a role in the initial cellular activation. To
better define the nature of this viral induction of Sp1 and
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NF-kB and to determine if a factor associated with the HCMV
membrane envelope mediates the response, we enriched for
viral envelope-membrane components and then used these
products as cellular activators to test for transcription factor
upregulation. Incubation of the purified membrane extract
fractions with HEL fibroblasts for 60 min induced both Sp1
(Fig. 2A) and NF-kB (Fig. 2B) EMSA activities (compare the
Mem lanes—incubation of cells with the purified membrane
fractions— to the untreated Mock lanes), demonstrating that
the signaling was mediated by a viral membrane constituent.
The membrane-mediated induction of Sp1 and NF-kB activity
could be blocked by preincubation (for 60 min) of the mem-
brane samples with affinity-purified monoclonal anti-gB (15D8
[60]) and -gH (1G6 [61]) antibodies (compare the Mem lanes
to the antibody-treated membrane fraction [Mem1agBgH]
lanes). Preincubation of the purified membrane extracts with
an identical concentration of an isotype- and species-matched,
nonspecific control antibody (Cont Ab lane) had no effect on
the signaling capacity of these extracts. Examination of the
membrane fractions by Western blot analysis confirmed the
presence of the envelope glycoproteins and the purity of the
FIG. 1. HCMV infection results in rapid upregulation of Sp1 and NF-kB
DNA binding activity. (A) EMSA of a time course of Sp1 DNA binding activity
following infection with live or UV-inactivated, gradient-purified HCMV (mul-
tiplicity of infection, 2 to 3) of HEL fibroblasts. (B) Time course of NF-kB DNA
binding following infection with purified live or UV-inactivated virus. (C) EMSA
confirming the specificity of the induced Sp1 products via supershift experiments
and binding of extracts to mutant probes. (D) EMSA confirming the specificity
of the induced NF-kB products. Mock lanes contained uninfected fibroblasts
treated in a manner identical to that of infected cells, except that no virus was
added and they were incubated for the maximal length of sample stimulation.
ATF/CREB DNA binding was not induced at IE times after infection (data not
shown). The time course of infection represents the times of cell harvesting
following virus addition. The binding of harvested HEL nuclear extracts to a
consensus WT (59-CCTTTTTAAGGGGCGGGGCTT-39) or MUT (59-CCTTT
TTAAGGTTCGGGGCTT-39) GC BOX and a WT (59-CCTTTTTTTTTGGG
GATTCCCCA-39) or MUT (59-CCTTTTTTTTTGCGGCTTCCCGA-39) MHC
binding site was assessed. The specific (Sp1 and supershifted Sp1 [asterisks],
p50/p65 and p50/p50 complexes, and supershifted p50 and p65 complexes [as-
terisks]) and nonspecific (NS) bands are labeled. Santa Cruz anti-Sp1 antibody
(lane aSp1) and the appropriate blocking peptide (lane aSp11pep) and specific
anti-p50 and -p65 antibodies (lanes ap65 and ap50 [14, 63]) and their appropri-
ate blocking peptides (lanes ap651pep and ap501pep) were used in the super-
shift experiments. In addition, competition experiments with unlabeled compet-
itors were also done to show the specificity of the bound products (data not
shown). hpi, hours postinfection.
FIG. 2. Purified HCMV membrane fractions can modulate cellular transcrip-
tion factor activity. (A) Changes in Sp1 DNA binding activity were examined in
EMSAs by using lysates from HEL fibroblasts harvested following 60 min of
incubation with either purified virus (Virus lane), purified viral envelope extracts
(Mem lane; the same protein amount as was used with the purified virus), or
purified envelope fractions preincubated for 60 min with affinity-purified anti-gB
(15D8 [60]) and -gH (1G6 [61]) (Mem1agBgH lane) antibodies or a species-
and isotype-matched control antibody (Cont Ab [the anti-PSA antibody]). The
Mock lane contained untreated cells handled the same way as treated cells except
that no membrane extract was added and they were incubated for the same
length of time as the test samples. (B) NF-kB DNA binding activity was analyzed
in EMSAs by using lysates from fibroblasts harvested following incubation for 60
min with either purified virus (Virus lane), purified viral envelope fractions
(Mem lane), or purified envelope fractions preincubated for 60 min with affinity-
purified anti-gB and -gH (Mem1agBgH lane) antibodies or the appropriate
control antibody (Cont Ab [anti-PSA antibody). The Mock lane contained un-
treated cells handled the same way as treated cells, except that no membrane
extract was added and they were incubated for the same length of time as the test
samples. (C) The purity of the collected viral envelope fractions was demon-
strated by Western blot analysis of the purified virion and viral membrane
fractions. Samples were probed with antibodies specific for UL94 (74), gB (Ad-
vanced Biotechnologies Inc.), IE1-72 (78), or pp65/UL83. NS, nonspecific.
5054 YUROCHKO ET AL. J. VIROL.
isolated fractions (Fig. 2C). UL94, a known capsid-associated
HCMV gene product that is not found on the viral envelope
(74); IE1-72, which we have previously documented to be
present in the virion (74); and pp65/UL83 were all absent from
our purified membrane extract fractions. The results of these
experiments identify constituents of the viral membrane as the
source of the early signaling event and suggest that viral gly-
coproteins gB and gH are the viral ligands responsible for this
signaling process.
Antibody neutralization of viral glycoproteins gB and gH
could prevent transcription factor upregulation. To confirm
that viral membrane products mediated the induction of cel-
lular factors, we further examined the role of the two primary
membrane glycoproteins, gB and gH, by preincubating gradi-
ent-purified virus with a combination of specific neutralizing
monoclonal antibodies (anti-gB [15D8] and -gH [1G6]) for 60
min prior to virus incubation with HEL fibroblasts. Preincuba-
tion of virus with these neutralizing antibodies blocked the
increase in both Sp1 (Fig. 3) and NF-kB (Fig. 4) DNA binding
activities seen with purified virus alone (compare the untreat-
ed/no-antibody (—) lanes to the antibody-treated (agB&gH)
lanes. Specifically, Fig. 3A and 4A demonstrated that preincu-
bation of purified virus with anti-gB and -gH antibodies (4 mg
of each) significantly blocked transcription factor upregulation
at various early times postinfection (0.5 and 4 h postinfection).
The antibody-mediated effect was dose dependent, because as
the antibody concentration was increased from 4 to 20 mg, Sp1
and NF-kB induction was nearly completely blocked (Fig. 3B
and 4B, respectively). Incubation of the gradient-purified virus
with a similar concentration of a species- and isotype-matched
control antibody had no effect on Sp1 (Fig. 3B) or NF-kB (Fig.
4B) signaling. Incubation of HEL fibroblasts with either anti-
body alone or antibody plus complement under the same con-
ditions that were used for virus incubation or antibody-treated
virus incubation had no effect on Sp1 or NF-kB levels or cell
viability. In addition, in comparison experiments the neutral-
izing function of these antibodies was tested under similar
conditions used to block transcription factor expression and
was shown to prevent cytopathic effects and viral gene expres-
sion (results not shown).
Blocking of transcription factor induction by individual gB
and gH antibodies. To broaden our examination of the ability
of a different neutralizing antiserum to block the cellular sig-
naling pathway, we preincubated purified virus with individual
monoclonal anti-gB or gH antibodies. The 15D8 (agB-15D8)
and 1G6 (agH-1G6) antibodies inhibited Sp1 (Fig. 5A) and
NF-kB (Fig. 5B) activities when used alone. In addition, by
using a panel of available anti-gB monoclonal antibodies (agB-
CH177-3, -CH432-1, and -CH436-1 [54, 59]) specific for dif-
ferent regions of the gB molecule, we also blocked transcrip-
tion factor regulation. In contrast, the nonspecific isotype- and
species-matched control anti-PSA antibody, when preincu-
bated with virus, had no effect on the signaling cascade. Non-
neutralizing gB antibodies (59) appeared to have no effect on
the ability of purified HCMV to initiate the induction of nu-
clear Sp1 and NF-kB levels (76). These results support the
involvement of the viral gB and gH glycoproteins in the early
stage of the signaling cascade.
Purified HCMV gB induced Sp1 and NF-kB DNA binding
upon cellular binding. The observations described above raise
the possibility that the initial cellular induction by HCMV is
due to viral ligand-receptor interactions. We next wanted to
show that specific viral ligands are directly capable of inducing
cellular transcription factors. Purified HCMV gB was incu-
bated under conditions similar to those used for viral infection
or treatment of cells with the membrane extracts. A 60-min
incubation of purified HCMV gB with fibroblasts (lanes gB)
induced Sp1 (Fig. 6A) and NF-kB (Fig. 6B) activities above
those seen in untreated control cells with both amounts of gB
used (15 and 60 ng). The flowthrough control, which was iso-
lated from extracts from the parental 293T cells (no trans-
fected gB) by the same procedure used to purify the gB,
showed no ability to activate cellular transcription factors, thus
demonstrating that the protocol used to purify gB did not itself
have a mitogenic effect. Furthermore, the effects mediated by
purified gB could be blocked by pretreatment with anti-gB
antibody (15D8; compare lanes treated with antibody (agB Ab
lanes) to those without) but not by pretreatment with an iso-
FIG. 3. Neutralizing antibodies to gB and gH block Sp1 induction. (A)
EMSA of a time course of Sp1 DNA binding activity from HEL fibroblasts fol-
lowing infection with gradient-purified HCMV without or with pretreatment with
neutralizing antibody (4 mg, preincubated for 60 min with anti-gB [15D8] and -gH
[1G6] affinity-purified serum; lanes agB&gH). (B) EMSA of Sp1 DNA binding
following infection with purified virus or purified virus preincubated with 4 or 20
mg of anti-gB and -gH serum or 20 mg of an isotype- and species-matched control
antibody (Cont Ab). See the Fig. 1 legend for a description of Mock lanes. The
— lane contained cells infected with purified virus that were not preincubated
with antiglycoprotein serum. NS, nonspecific; hpi, hours postinfection.
FIG. 4. Neutralizing antibodies to gB and gH also block NF-kB induction.
(A) EMSA of a time course of NF-kB DNA binding activity following infection
of fibroblasts with purified HCMV or neutralized HCMV (preincubated with 4
mg of affinity-purified anti-gB and -gH serum for 60 min; lanes agB&gH). (B)
EMSA of NF-kB DNA binding following infection with purified virus or purified
virus preincubated with 4 and 20 mg of anti-gB and -gH serum or 20 mg of an
isotype- and species-matched control monoclonal antibody (Cont Ab). See the
Fig. 1 legend for a description of the Mock lane samples. The — lane contained
cells infected with purified virus that were not preincubated with antiglycoprotein
serum. NS, nonspecific; hpi, hours postinfection.
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type-matched control antibody (Cont Ab lanes). The signifi-
cant increase in Sp1 and NF-kB activities following the incu-
bation of cells with the purified gB product and the inhibition
of these activities by anti-gB antibody demonstrated that the
specific gB-receptor interaction could directly initiate signal-
ing.
Interaction of an anti-idiotypic antibody that mimics gH
with the gH cognate receptor also upregulated the signal
transduction pathway. To show that the viral gH product also
played a role in transcription factor induction, we used a well-
characterized affinity-purified anti-idiotypic monoclonal (aId)
antibody (38, 40–43) which antigenically mimics the viral gH
product and binds to the same 92.5-kDa cell membrane pro-
tein as affinity-purified gH (42) to stimulate cells. The anti-
idiotypic antibody (4-3-5) or the appropriate control (a non-
specific IgM) was preincubated for 60 min with a cross-linking
(X-L) secondary antibody prior to 60 min of incubation with
cells. The results of these experiments demonstrated that the
engagement of the gH cellular receptor (lanes aId1X-L)
could upregulate Sp1 (Fig. 7A) and NF-kB (Fig. 7B) DNA
binding. The controls, i.e., the nonspecific IgM antibody plus
the cross-linking antibody (aIgM Control1X-L) or the cross-
linking antibody alone (X-L alone), could not induce transcrip-
tion factors, thus demonstrating the specificity of the Sp1 and
NF-kB upregulation via the gH anti-idiotypic antibodies.
DISCUSSION
The data demonstrates that a bona fide signal transduction
event takes place following HCMV binding to the cell and that
viral membrane constituents mediate this signaling event.
More specifically, our results document that HCMV glycopro-
teins gB and gH are critical players in the induction of Sp1 and
NF-kB during infection. Because of the essential role host
cellular factors play during HCMV infection, these results sug-
gest a model in which the receptor-ligand-mediated signaling
event results in a burst of transcription factors that is vital for
the initial induction of the important viral gene products which
require cellular transcription factors for expression (9, 13, 28,
33, 62, 66). This data is supported by studies demonstrating
that many viruses, including other members of the herpesvirus
family, bind to known “activational” receptors (6, 20, 21, 48,
53, 56, 65, 68, 72). Although these studies neither directly
examined nor demonstrated stimulation of cellular activation
by viral binding, the conclusions drawn from these studies
FIG. 5. Neutralization of purified HCMV with a panel of antibodies specific
for gB and gH. (A) Measurement of Sp1 binding activity from nuclear lysates of
harvested HEL fibroblasts incubated with either purified HCMV or purified
HCMV preincubated for 60 min with anti-gB or -gH antibodies or an isotype-
matched control antibody (Cont Ab). (B) Examination of NF-kB DNA binding
activity of nuclear lysates harvested from fibroblasts incubated with either puri-
fied HCMV or purified HCMV preincubated with various antiglycoprotein (anti-
gB or -gH) and control antibodies. The agB-CH177-3, -CH432-1, and -CH436-1
antibodies (54, 59) were used as ascites fluid, while all of the other antibodies
(agB-15D8, agH-1G6, and the control antibody) were used as affinity-purified
antiserum. For a description of the Mock lanes, see the Fig. 1 legend. NS,
nonspecific; hpi, hours postinfection.
FIG. 6. Purified viral gB elicits a cellular response. (A) EMSA of Sp1 from
nuclear lysates harvested from fibroblasts after 60 min of incubation with gradi-
ent-purified virus, purified gB (15 and 60 ng), or a flowthrough control lysate
treated in the same manner as the purified gB (FT Control). In addition, in a
replicate experiment, cells were treated with 5 mg of anti-gB (15D8 [agB Ab]) or
the appropriate control antibody (Cont Ab) for 60 min prior to incubation. (B)
EMSA of NF-kB from nuclear lysates of fibroblasts treated with gradient-puri-
fied virus, purified gB, flowthrough control, or purified gB or flowthrough control
lysate pretreated with anti-gB antibody or a control antibody. For a description
of the Mock lanes samples, see the Fig. 1 legend. NS, nonspecific.
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tantalizingly hinted that this process might occur. Therefore,
our present findings, along with those of past studies, support
a hypothesis that viruses have evolved a common strategy to
bind to a normally used activational molecule or receptor to
facilitate not only viral entry but also cellular activation and,
presumably, viral survival.
We have shown that there is a rapid increase in the levels of
nuclear Sp1 and NF-kB DNA binding activity following the
incubation of purified virus with fibroblasts, confirming the
results of previous studies (9, 49, 62, 78, 79). In addition, the
data suggested that the induction of these factors (Sp1 and
NF-kB) was specific because ATF/CREB was not induced
following viral binding (data not shown), supporting the results
of Kerry et al. (44), who showed that ATF was upregulated
only at late times of infection. The rapid induction of these
cellular transcription factors is sufficient to account for the
documented IE expression of the proto-oncogenes c-fos, c-jun,
and c-myc (8), in which NF-kB and Sp1 have been documented
to play a regulatory role (12, 26, 27, 45, 46, 52, 70). It could be
argued that this IE signaling event was due to a mitogenic
factor secreted by the infected cells from which we purified the
virus. This possibility, however, was unlikely because when
density gradient-purified virus was used, upregulation of tran-
scription factors was still observed. In addition, UV-inactivated
virus also induced cellular transcription factors. These findings
are similar to those of work examining proto-oncogene expres-
sion, in which it was shown that density gradient-purified virus
and inactivated virus had identical effects on proto-oncogene
mRNA levels (8). Lastly, the antibody blocking studies sup-
ported this notion, because if a soluble mitogenic factor had
been copurified with the virus, its effect would not have been
specifically inhibited by the anti-HCMV antibodies.
Because the kinetics of the transcription factor induction
was similar to that seen in systems in which receptor-ligand
interactions are known to mediate the signaling event (5, 7, 64,
69, 76), we next wanted to determine that the viral products
responsible for this rapid transcription factor induction are
restricted to the viral membrane. Therefore, we enriched for
the viral envelope fraction and used these products to stimu-
late cells. These envelope extract fractions stimulated Sp1 and
NF-kB activity, supporting our hypothesis that ligands on the
virus surface mediate the induction of Sp1 and NF-kB activity.
Because anti-gB and -gH antibodies could block this stimula-
tion and the isotype-matched control antibody could not, the
data strongly hinted that it was these glycoproteins that were
intimately involved with cellular regulation. Additionally, these
results showed that the signaling was not due to a capsid- or
tegument-associated product. Neutralizing monoclonal anti-
bodies against gB and gH (together or alone) blocked the
virus-mediated signal transduction event, providing additional
support that it was, in fact, these viral ligands that mediated
host cell transcription factor activation. Interestingly, nonneu-
tralizing antibodies to gB (59) could not block the signaling
cascade initiated by viral binding to the cell surface (77).
To further define the role the HCMV glycoproteins play in
cellular signaling, purified HCMV gB and a well-characterized
anti-idiotypic antibody (38, 40–43) that mimics the HCMV gH
molecule were used. Purified gB directly stimulated host cell
factors, whereas the control lysate could not. Furthermore,
anti-gB antibodies specifically inhibited the purified gB-regu-
lated transcription factor induction, while control antibodies
did not, demonstrating that gB-receptor interaction could elicit
the appropriate signal for the upregulation of Sp1 and NF-kB
activity. The gH anti-idiotypic antibodies also induced these
host cellular products, while the isotype control antibodies
could not. Because these antibodies also generated an increase
in [Ca21]i flux (40) and stimulated phosphorylation of the
92.5-kDa receptor (41), our results confirmed that gH receptor
engagement could regulate a signaling event and, more impor-
tantly, showed that the engagement of the cellular gH 92.5-
kDa receptor also provided the appropriate signal to upregu-
late Sp1 and NF-kB activity. Together, these studies define the
HCMV gB and gH glycoproteins as active players in the signal
transduction cascade and demonstrate that they can mediate a
specific and sufficient signal to induce cellular activation. It is
important to point out that there are other potential HCMV
glycoproteins (10, 11, 19, 35, 37, 57, 58), and it is certainly
possible that some of these gene products also play a role in
vivo, particularly depending on the mechanism of virus trans-
mission and/or the cell type infected.
The specific component(s) of the cellular pathway utilized by
the virus following gB and/or gH engagement of their respec-
tive cellular receptors is unknown because little is known about
the cellular receptors to which gB and gH bind and their
intracellular signaling capacity. The rapid upregulation of nu-
clear NF-kB, however, probably results from the typical path-
way of activation for this factor following receptor-ligand in-
teraction, i.e., the mobilization to the nucleus of preformed
FIG. 7. Anti-idiotypic antibodies which mimic the HCMV gH glycoprotein
can upregulate Sp1 and NF-kB EMSA activity. (A) EMSA of Sp1 binding activity
from nuclear lysates following 60 min of incubation of fibroblasts with either
purified virus, anti-idiotypic antibody (an IgM) plus the appropriate anti-IgM
cross-linking antibody (aId1X-L), nonspecific IgM antiserum plus the cross-
linking antibody (aIgM Control1X-L), or the cross-linking antibody alone (X-L
alone). (B) EMSA examining NF-kB activity from nuclear lysates of fibroblasts
treated with either purified virus, a specific anti-idiotypic antibody plus the
appropriate cross-linking antibody (aId1X-L), nonspecific control antiserum
plus the cross-linking antibody (aIgM Control1X-L), or the cross-linking anti-
body alone (X-L alone). For a description of the Mock lanes, see the Fig. 1
legend. NS, nonspecific.
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NF-kB from its cytosolic storage via the phosphorylation and
proteasome-mediated degradation of IkBa or one of its other
potential inhibitors (reviewed in references 5, 25, 64, and 69).
Also probably involved is the Ras–Raf–mitogen-activated pro-
tein kinase signaling cascade, because these elements have
been shown to be upstream of the phosphorylation and deg-
radation of IkBa during receptor-ligand-mediated NF-kB
stimulation (5, 25, 64, 69). The signaling pathway involved in
the upregulation of Sp1 is unknown. It may involve some of the
same components that are utilized in the regulation of NF-kB,
i.e., the activation of certain regulatory kinases or phospha-
tases. Because these two products are differentially regulated
in most documented cases, however, a divergent pathway is
most likely used, perhaps one that targets the Sp1 regulatory
molecule(s) (12, 46, 51, 52, 70, 71).
Our model describing the multiple levels of host cell tran-
scription factor regulation can now be expanded to include our
new results. As shown here, an initial induction of cellular
factors occurs via gB and gH interaction with their appropriate
cellular receptors. Following this receptor-ligand-mediated ini-
tial induction of cellular factors, we believe that there is an
amplification of the signal by a virion-associated product(s)
prior to induction of the IE genes. We have preliminary evi-
dence that the HCMV capsid lacking an envelope upregulates
host cell factors (77) and that a virion-associated kinase can
phosphorylate IkBa (73). Perhaps, this product(s) is function-
ally analogous to the hepatitis B virus HBx protein (67), the
human immunodeficiency virus Tat protein (22), or the human
T-lymphotropic virus type I Tax1 protein (50), at least in regard
to its intracellular role in NF-kB activation. And lastly, as we
have previously shown, viral IE genes can transactivate these
cellular promoters and function along with the increased levels
of cellular factors to maintain the high levels of these factors
during the course of infection (76, 78). Overall, the data dem-
onstrates that multiple pathways are utilized by HCMV for
regulation of the vital transcription factors necessary for the
maintenance and regulation of the viral life cycle (also pre-
sumably one of the underlying causes for the pathogenicity of
the virus itself). In conclusion, we have defined a very early
virus-regulated step that is responsible for the regulation of
host cell factors involving the receptor-ligand interaction be-
tween the viral gB and gH glycoproteins and their cognate
receptors.
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